Information
Code | FAR654 |
Name | |
Term | 2024-2025 Academic Year |
Term | Fall and Spring |
Duration (T+A) | 2-0 (T-A) (17 Week) |
ECTS | 5 ECTS |
National Credit | 2 National Credit |
Teaching Language | Türkçe |
Level | Doktora Dersi |
Type | Normal |
Mode of study | Yüz Yüze Öğretim |
Catalog Information Coordinator | |
Course Instructor |
1 |
Course Goal / Objective
The aim of this course is to provide the student with a general knowledge and equipment in the field of nanopharmacology.
Course Content
Nanopharmacology in cancer treatment: Signaling pathways in cancer-I, Nanopharmacology in cancer treatment: Signaling pathways in cancer-II, Nanopharmacology in cancer treatment: Signaling pathways in cancer-III, Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-I, Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-II, Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-III, Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-I, Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-II, Regenerative nanopharmacology: Treatments of cardiac and neurological injuries-III, Nanopharmacology of Addiction: Gene therapy-I, Nanopharmacology of Addiction: Gene therapy-II, Nanopharmacology and Pharmacogenomics in Personalized Medicine-I, Nanopharmacology and Pharmacogenomics in Personalized Medicine-II, Nanopharmacology and Pharmacogenomics in Personalized Medicine-III
Course Precondition
Not required.
Resources
Scientific database
Notes
Scientific database
Course Learning Outcomes
Order | Course Learning Outcomes |
---|---|
LO01 | Explains the importance of nanopharmacology in cancer treatment. |
LO02 | Describes the use of nanopharmacology in cardiovascular diseases. |
LO03 | Explain regenerative nanopharmacology and nanopharmacology of addiction. |
LO04 | Tell nanopharmacology and pharmacogenomics in personalized medicine. |
Relation with Program Learning Outcome
Order | Type | Program Learning Outcomes | Level |
---|---|---|---|
PLO01 | Beceriler - Bilişsel, Uygulamalı | Discusses the mechanisms of action, side effects, and toxic effects of drugs. | 3 |
PLO02 | Beceriler - Bilişsel, Uygulamalı | Explains drug effects, drug interactions and effects on organ systems with a systematic approach | 3 |
PLO03 | Yetkinlikler - Alana Özgü Yetkinlik | Plans, implements and finalizes a scientific project | |
PLO04 | Bilgi - Kuramsal, Olgusal | Recognize the research areas and research techniques of pharmacology | 3 |
PLO05 | Yetkinlikler - Alana Özgü Yetkinlik | Comparatively examines and compiles scientific articles in the field of pharmacology. | |
PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Prepares the experimental setup for an in vitro or in vivo pharmacological study and solves problems. | |
PLO07 | Yetkinlikler - Alana Özgü Yetkinlik | He/she transforms the data obtained from the research project into a scientific research article. | |
PLO08 | Yetkinlikler - Alana Özgü Yetkinlik | Evaluates drug use and its effects in society due to his/her knowledge about drugs. | |
PLO09 | Bilgi - Kuramsal, Olgusal | Explain clinical phase studies in drug development. | |
PLO10 | Beceriler - Bilişsel, Uygulamalı | Evaluates and interprets study data statistically. | |
PLO11 | Beceriler - Bilişsel, Uygulamalı | contributes to public health with its awareness of rational drug use. |
Week Plan
Week | Topic | Preparation | Methods |
---|---|---|---|
1 | Nanopharmacology in cancer treatment: Signaling pathways in cancer-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
2 | Nanopharmacology in cancer treatment: Signaling pathways in cancer-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
3 | Nanopharmacology in cancer treatment: Signaling pathways in cancer-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
4 | Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
5 | Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
6 | Nanopharmacology in cardiovascular diseases: Arrhythmias and structural defects-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
7 | Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
8 | Mid-Term Exam | Ölçme Yöntemleri: Yazılı Sınav, Sözlü Sınav |
|
9 | Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
10 | Regenerative nanopharmacology: Treatments of cardiac and neurologic injuries-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
11 | Nanopharmacology of Addiction: Gene therapy-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
12 | Nanopharmacology of Addiction: Gene therapy-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
13 | Nanopharmacology and Pharmacogenomics in Personalized Medicine-I | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
14 | Nanopharmacology and Pharmacogenomics in Personalized Medicine-II | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
15 | Nanopharmacology and Pharmacogenomics in Personalized Medicine-III | books and scientific databases | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
16 | Term Exams | Ölçme Yöntemleri: Yazılı Sınav, Sözlü Sınav |
|
17 | Term Exams | Ölçme Yöntemleri: Yazılı Sınav, Sözlü Sınav |
Student Workload - ECTS
Works | Number | Time (Hour) | Workload (Hour) |
---|---|---|---|
Course Related Works | |||
Class Time (Exam weeks are excluded) | 14 | 3 | 42 |
Out of Class Study (Preliminary Work, Practice) | 14 | 3 | 42 |
Assesment Related Works | |||
Homeworks, Projects, Others | 0 | 0 | 0 |
Mid-term Exams (Written, Oral, etc.) | 1 | 15 | 15 |
Final Exam | 1 | 30 | 30 |
Total Workload (Hour) | 129 | ||
Total Workload / 25 (h) | 5,16 | ||
ECTS | 5 ECTS |